JABIL Earnings Preview: Recent $JBL Insider Trading, Hedge Fund Activity, and More

JABIL ($JBL) is set to release quarterly earnings on June 17th, with analysts anticipating revenue of $7.10 billion and EPS of $2.31. Over the past six months, JABIL insiders have sold shares 23 times with no purchases, while Q1 2025 saw mixed hedge fund activity, including FMR LLC reducing its position by 1,742,979 shares and Wellington Management Group LLP increasing its stake by 747,423 shares; Barclays issued an "Overweight" rating on March 21, 2025.

Analysis

JABIL ($JBL) is scheduled to report its quarterly earnings on June 17th before market open, with analysts anticipating revenue of $7.10 billion and earnings per share of $2.31. A key observation is the significant insider selling activity over the past six months, totaling 23 transactions, all of which were sales, and zero purchases. Notable sales include those by John C Plant (50,000 shares for an estimated $8.63 million), Executive Chairman Mark T Mondello (40,000 shares for ~$5.97 million), and CEO Michael Dastoor (10,000 shares for ~$1.7 million). This pattern of consistent selling by top executives warrants attention. Institutional activity in Q1 2025 presents a mixed picture: 418 institutions added to their JABIL positions while 378 reduced theirs. Significant divestitures include FMR LLC selling 1.74 million shares (-31.5%) and Alyeska Investment Group liquidating its entire position of 810,727 shares. Conversely, Wellington Management Group increased its holding by 747,423 shares (+12.9%), Jacobs Levy Equity Management substantially grew its position by 662,938 shares (+119.9%), and Lord, Abbett & Co. LLC initiated a significant new position of 598,063 shares. Despite the insider sales and some institutional reductions, Barclays issued an "Overweight" rating on March 21, 2025. The overall sentiment score for JABIL is moderately negative (-0.6), reflecting the concerning insider transaction data.

Key Decisions for Investors

• Investors should closely scrutinize the upcoming June 17th earnings release, particularly for any deviations from the $7.10 billion revenue and $2.31 EPS estimates, and closely analyze management's forward guidance.
• The consistent and substantial insider selling, with 23 sales and no purchases in the last six months, should be considered a significant cautionary signal regarding internal sentiment towards the stock's near-term prospects.
• Evaluate the divergent institutional activity, weighing the positive analyst rating from Barclays and new significant stakes by some funds against the large position reductions or complete exits by other major institutional investors like FMR LLC and Alyeska Investment Group.
• Given the moderately negative sentiment and pronounced insider sales, investors might consider a cautious stance or review risk exposure leading into the earnings announcement.